References
Feng Y, Qi S, Liu X, Zhang L, Hu Y, Shen Q, et al. Have we been qualifying measurable residual disease correctly? Leukemia. 2023. https://doi.org/10.1038/s41375-023-02026-4.
Latham S, Hughes E, Budgen B, Mechinaud F, Crock C, Ekert H, et al. Sources of error in measurement of minimal residual disease in childhood acute lymphoblastic leukemia. PLoS One. 2017;12:e0185556.
Author information
Authors and Affiliations
Contributions
This letter does not contain original research, has not been published elsewhere, has not been submitted for publication elsewhere and is exclusively the contribution of the author.
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Morley, A.A. Quantifying measurable residual disease correctly. Leukemia 38, 221–222 (2024). https://doi.org/10.1038/s41375-023-02106-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-023-02106-5
- Springer Nature Limited